// App-Quantinova.ai

TCT-375 : Comparison of Long Term Outcome After First- and Second-Generation Drug-Eluting Stents in the Treatment of Chronic Total Occlusions: Insights From a Large Registry of 1,343 Consecutive Patients

Researchers

Presenter

  • Francesca Sanguineti

Principal Investigators

  • Yves Louvard

  • Stephen -Connor

  • Yusuke Watanabe

  • Carlos J Garcia Alonso

  • Thierry Lefevre

  • Thomas Hovasse

  • Marie-Claude Morice

  • Philippe Garot

Medical Centers

  • Institut Cardiovasculaire Paris Sud, Generale de Sante, Massy, France

  • Institut Cardiovasculaire Paris Sud, Massy, France

  • Institut Cardiovasculaire Paris Sud, Generale de Sante, Massy, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Chronic total occlusion

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

  • Paclitaxel

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved